About APOE

The APOE gene (apolipoprotein E) on chromosome 19q13.32 encodes a glycoprotein involved in lipid metabolism and cholesterol transport. The APOE ε4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease. APOE spans ~3.6 kb with 4 coding exons, making it one of the smallest clinically important genes for primer design.

NCBI Gene ID: 348 | RefSeq: NM_000041.4 | Genomic: NC_000019.10 (44905791-44909393)

APOE Primer Design Challenges

  • Allele discrimination: ε2 (rs7412) and ε4 (rs429358) differ by single nucleotides in exons 4, requiring allele-specific primers or RFLP-based design
  • Small gene size: Only ~3.6 kb limits intronic primer placement options between exons
  • GC-rich regions: Exon 4 has ~60% GC content around the ε2/ε3/ε4 polymorphic sites
  • High sequence homology: APOE promoter region shares homology with APOC1 pseudogene nearby
  • Multiplex compatibility: Genotyping assays often require multiplex PCR with internal controls

Recommended Primer Design Parameters for APOE

ParameterStandard Exons (1–3)Exon 4 (Genotyping)
Primer length20-22 nt22-26 nt
GC content45-55%50-60%
Tm58-62°C60-66°C
Amplicon size150-300 bp200-300 bp
Annealing temp58-60°C62-65°C (for allele-specific)
PCR additiveStandard3-5% DMSO for GC-rich regions

Key SNPs to Avoid in Primer Binding Sites

When designing APOE primers, account for these defining polymorphisms:

  • rs429358 (c.388T>C, p.Cys130Arg) — Defines ε4 allele; critical for Alzheimer's risk genotyping
  • rs7412 (c.526C>T, p.Arg176Cys) — Defines ε2 allele; protective against Alzheimer's
  • rs440446 — Promoter variant affecting gene expression levels
  • rs405509 (T>G promoter SNP) — Associated with altered APOE expression
  • rs769449 — Intron 1 variant in LD with ε4, useful for tagging

Clinical Validation Required
All APOE primers designed with VigyanLLM are for research use only. Clinical diagnostic applications require additional wet-lab validation, Sanger sequencing confirmation, and regulatory approval before patient use.

Recommended Primer Sequences for APOE — Engine-Designed on NM_000041.4

The three pairs below were produced by VigyanLLM's automatic primer design engine directly against the Homo sapiens APOE RefSeq mRNA NM_000041.4 (1166 nt), under the engine's default constraints: 18–25 nt primers, Tm 57–72 °C (optimum 62 °C), GC 40–60%, and an 80–1500 bp amplicon (optimum 150 bp). Every oligo was then re-checked back against the accession — each forward primer matches the sense strand at its stated 1-based position and each reverse primer matches the reverse complement ending at the amplicon's final base (3 of 3 exact matches for this page).

PairForward (5′→3′)Reverse (5′→3′)Tm fwd / revGC fwd / revAmplicon
15′-AGGTTCTGTGGGCTGCGTTG-3′5′-TCCCAAAAGCGACCCAGTGC-3′64.0 / 64.0 °C60.0 / 60.0%154 bp (nt 74–227)
25′-TGCGTTGCTGGTCACATTCC-3′5′-GGTAATCCCAAAAGCGACCCAG-3′62.2 / 62.2 °C55.0 / 54.5%146 bp (nt 87–232)
35′-TGAAGGTTCTGTGGGCTGC-3′5′-TCCCAAAAGCGACCCAGTG-3′60.9 / 60.9 °C57.9 / 57.9%157 bp (nt 71–227)

Pair 1 leads with a forward/reverse Tm spread of 0.0 °C, no stable hairpin at 37 °C (ΔG ≥ 0.0 kcal·mol−1 on either oligo), self-dimer Tm at most -11.6 °C, no cross-dimer signal, no pair warnings, and a Primer3 pair-quality score of 96.0/100; the suggested starting annealing temperature is 59.0 °C. Pairs 2 and 3 are alternates from the same run — compare their Tm, GC and product columns above against your chemistry (dye-based or probe), then confirm every candidate in silico and on a gel before use.

Specificity status: inconclusive — not confirmed.
Alongside the design the engine ran an automated Primer-BLAST query (Homo sapiens, RefSeq mRNA); the parser found no expected target in the report, so the “complete” status must not be read as a pass. Run NCBI Primer-BLAST yourself on every pair you intend to use, with settings that match your template (gDNA vs cDNA).

How to read this table: these are default whole-transcript designs — they demonstrate what the engine produces under standard constraints and are not positioned over the clinically relevant variants discussed below; to land an amplicon on a specific codon or repeat, design against that region deliberately. Thermodynamics come from Primer3's nearest-neighbor engine (SantaLucia 1998). Example output only: validate each candidate experimentally (gel sizing, efficiency series, melt-curve or probe check) before relying on it.

Design Guidance for APOE Assays

APOE is a lipid-transport protein with three common isoforms — ε2, ε3 and ε4 — defined by just two coding SNPs: rs429358 (c.388T>C) and rs7412 (c.526C>T). Their haplotypes give the isoforms (Cys/Cys, Cys/Arg and Arg/Arg at the two positions in the historical mature-protein numbering 112/158), and ε4 is the best-established genetic risk factor for late-onset Alzheimer's disease.

Because the two sites are only 138 nt apart in coding coordinates (c.526 − c.388), a single short amplicon can span both: design one product across c.388–c.526 and read it by Sanger sequencing, or run two allele-discrimination reactions (hydrolysis probes are the usual choice because each site is a single-base change). Note that the example pair above (nt 74–227 of NM_000041.4) sits upstream of both variant sites — it demonstrates default engine output, not a genotyping assay; for APOE typing, design the amplicon so it spans both sites. Allele-specific formats place the variant base at the 3′ end of the specific primer; otherwise keep both primers variant-free so neither allele drops out.

Practical checklist: (1) verify the binding sites in dbSNP/gnomAD so a common polymorphism does not sit under a primer; (2) confirm specificity against cDNA or gDNA as appropriate; (3) gradient the annealing temperature around 59.0 °C; (4) confirm one product of the expected size on a gel; (5) document sequence, lot, efficiency and transcript — MIQE-level reporting is what makes a result publishable.

References

  • NCBI Nucleotide — RefSeq NM_000041.4 (Homo sapiens APOE mRNA).
  • NCBI Gene — APOE (Homo sapiens).
  • SantaLucia J Jr. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad Sci USA 1998;95:1460–1465.
  • Untergasser A, Cutcutache I, Koressaar T, et al. Primer3—new capabilities and interfaces. Nucleic Acids Res 2012;40:W115–W118.
  • Ye J, Coulouris G, Zaretskaya I, et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. Nucleic Acids Res 2009.
  • Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611–622.

Design APOE Primers Now

Pre-configured with APOE-specific parameters. Enter exon number or genomic coordinates.

Design APOE Primers →